| Distribution of miRNA expression across human tissues N Ludwig, P Leidinger, K Becker, C Backes, T Fehlmann, C Pallasch, ... Nucleic acids research 44 (8), 3865-3877, 2016 | 981 | 2016 |
| Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia CD Herling, N Abedpour, J Weiss, A Schmitt, RD Jachimowicz, O Merkel, ... Nature communications 9 (1), 727, 2018 | 203 | 2018 |
| Sensitizing protective tumor microenvironments to antibody-mediated therapy CP Pallasch, I Leskov, CJ Braun, D Vorholt, A Drake, YM Soto-Feliciano, ... Cell 156 (3), 590-602, 2014 | 191 | 2014 |
| miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia CP Pallasch, M Patz, YJ Park, S Hagist, D Eggle, R Claus, ... Blood, The Journal of the American Society of Hematology 114 (15), 3255-3264, 2009 | 178 | 2009 |
| Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia C Baer, R Claus, LP Frenzel, M Zucknick, YJ Park, L Gu, D Weichenhan, ... Cancer research 72 (15), 3775-3785, 2012 | 158 | 2012 |
| The kinase inhibitor dasatinib induces apoptosis in chronic lymphocytic leukemia cells in vitro with preference for a subgroup of patients with unmutated IgVH genes A Veldurthy, M Patz, S Hagist, CP Pallasch, CM Wendtner, M Hallek, ... Blood, The Journal of the American Society of Hematology 112 (4), 1443-1452, 2008 | 130 | 2008 |
| Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells CP Pallasch, J Schwamb, S Königs, A Schulz, S Debey, D Kofler, ... Leukemia 22 (3), 585-592, 2008 | 122 | 2008 |
| A role for PVRL4-driven cell–cell interactions in tumorigenesis NN Pavlova, C Pallasch, AEH Elia, CJ Braun, TF Westbrook, M Hemann, ... Elife 2, e00358, 2013 | 120 | 2013 |
| Detection of a novel truncating Merkel cell polyomavirus large T antigen deletion in chronic lymphocytic leukemia cells ND Pantulu, CP Pallasch, AK Kurz, A Kassem, L Frenzel, S Sodenkamp, ... Blood, The Journal of the American Society of Hematology 116 (24), 5280-5284, 2010 | 113 | 2010 |
| Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade CP Pallasch, S Ulbrich, R Brinker, M Hallek, RA Uger, CM Wendtner Leukemia research 33 (3), 460-464, 2009 | 105 | 2009 |
| Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor‐associated autoantibodies correlated with prolonged survival CP Pallasch, AK Struss, A Munnia, J König, WI Steudel, U Fischer, ... International journal of cancer 117 (3), 456-459, 2005 | 94 | 2005 |
| Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells U Kruse, CP Pallasch, M Bantscheff, D Eberhard, L Frenzel, S Ghidelli, ... Leukemia 25 (1), 89-100, 2011 | 84 | 2011 |
| Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease CP Pallasch, A Schulz, N Kutsch, J Schwamb, S Hagist, H Kashkar, ... Blood, The Journal of the American Society of Hematology 112 (10), 4213-4219, 2008 | 77 | 2008 |
| Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1 V Kohlhaas, SJ Blakemore, M Al-Maarri, N Nickel, M Pal, A Roth, ... Blood, The Journal of the American Society of Hematology 137 (5), 646-660, 2021 | 72 | 2021 |
| Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies I Leskov, CP Pallasch, A Drake, BP Iliopoulou, A Souza, CH Shen, ... Oncogene 32 (8), 1066-1072, 2013 | 63 | 2013 |
| B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides J Schwamb, V Feldhaus, M Baumann, M Patz, S Brodesser, R Brinker, ... Blood, The Journal of the American Society of Hematology 120 (19), 3978-3985, 2012 | 63 | 2012 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 62 | 2024 |
| miRs-138 and-424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL V Berg, M Rusch, N Vartak, C Jüngst, A Schauss, H Waldmann, ... Blood, The Journal of the American Society of Hematology 125 (19), 2948-2957, 2015 | 56 | 2015 |
| Corticosteroids inhibit Mycobacterium tuberculosis-induced necrotic host cell death by abrogating mitochondrial membrane permeability transition J Gräb, I Suárez, E van Gumpel, S Winter, F Schreiber, A Esser, ... Nature communications 10 (1), 688, 2019 | 54 | 2019 |
| Glioma-expressed antigen 2 (GLEA2): a novel protein that can elicit immune responses in glioblastoma patients and some controls U Fischer, AK Struss, D Hemmer, CP Pallasch, WI Steudel, E Meese Clinical & Experimental Immunology 126 (2), 206-213, 2001 | 53 | 2001 |
Michael HallekUniversity of CologneBestätigte E-Mail-Adresse bei uni-koeln.de
